H-TSAVLQSGFRKM-NH2

Ref. 3D-PP49937

Produktinformation

• Name: H-TSAVLQSGFRKM-NH2

Beschreibung

Peptide H-TSAVLQSGFRKM-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TSAVLQSGFRKM-NH2 include the following: Combining virtual screening with cis-/trans-cleavage enzymatic assays effectively reveals broad-spectrum inhibitors that target the main proteases of SARS-CoV-2 YJ Chang, UNP Le , JJ Liu, SR Li, ST Chao, HC Lai - Antiviral Research, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0166354223001316 Development of ultrapure and potent tannic acids as a pan-coronal antiviral therapeutic PC Shih , YW Mao, JW Hu, HY Hsieh - ACS Pharmacology & , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsptsci.1c00264 Biochemical characterization of recombinant enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay L Shang, S Zhang, X Yang, J Sun , L Li - Antimicrobial agents , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/aac.04698-14 Human Superantibodies to 3CLpro Inhibit Replication of SARS-CoV-2 across Variants K Glab-Ampai, K Kaewchim , T Saenlom - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/12/6587 Simeprevir potently suppresses SARS-CoV-2 replication and synergizes with remdesivir HS Lo , KPY Hui, HM Lai , X He, KS Khan - ACS central , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acscentsci.0c01186 Malonic Acid-Type Fullerene Derivatives Strongly Inhibit The SARS-Cov-2 Main Protease D Katagishi, D Yasuda, K Takahashi, S Nakamura - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1233840/latest Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate CJ Kuo, YH Chi , JTA Hsu, PH Liang - Biochemical and biophysical , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X04008526 SARS-CoV-2 3CLpro displays faster self-maturation in vitro than SARS-CoV 3CLpro due to faster C-terminal cleavage CJ Kuo, PH Liang - FEBS letters, 2022 - Wiley Online Libraryhttps://febs.onlinelibrary.wiley.com/doi/abs/10.1002/1873-3468.14337 Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents CJ Kuo, JJ Shie , JM Fang, GR Yen, JTA Hsu - Bioorganic & medicinal , 2008 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089608005634 Human coronavirus 3CL proteases cleave Septins and disrupt Hedgehog signaling, causing ciliary dysfunction AR Lee, YC Kweon, SM Lee - Journal of Medical , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.28618

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 1,323.6 g/mol